Asian Stock: China Resources Boya Bio-Pharmaceutical Group

By Andrew Stotz of Become A Better Investor
Saturday, September 2, 2023 10:25 PM EDT

TM Editors' note: This article discusses a penny stock and/or microcap. Such stocks are easily manipulated; do your own careful due diligence.

Company: China Resources Boya Bio-Pharmaceutical Group Company Limited

Bloomberg ticker: 300294 SZ

Market cap: US$2,479m

Background: China Resources Boya Bio-Pharmaceutical Group Company Limited manufactures pharmaceutical products. The Company mainly develops, produces, and sells blood products, diabetes drugs, anti-infective chemicals, biochemical drugs, and other products.
 

World Class Benchmarking of China Resources Boya Bio-Pharmaceutical Group

(Click on image to enlarge)

  • Profitable Growth rank of 4 was up compared to the prior period’s 5th rank
  • This is above average performance compared to 410 medium Health Care companies worldwide
  • Profitability rank of 4 was worse than its Growth rank of 3
  • Profitability rank of 4 was the same compared to the prior period’s 4th rank
  • This is above average performance compared to peers
  • Growth rank of 3 was up compared to the prior period’s 5th rank
  • This is above average performance compared to peers

More By This Author:

Asian Stock: Doosan Bobcat
Asian Stock: Heineken Malaysia
Thai Stock: Ichitan Group

Disclaimer: This content is for information purposes only. It is not intended to be investment advice. Readers should not consider statements made by the author(s) as formal recommendations and ...

more
How did you like this article? Let us know so we can better customize your reading experience.

Comments